Lionel Aurelien (Lionel) A. Kankeu Fonkoua, M.D.

  1. Oncologist

Location

  1. Rochester, Minnesota

Idiomas

EnglishFrench

Lionel A. Kankeu Fonkoua, M.D., is a medical oncologist specializing in the treatment of gastrointestinal cancers. His clinical focus includes:

  • Liver cancer
  • Biliary tract cancers
  • Stomach and esophageal cancer
  • Pancreatic cancer
  • Colorectal cancer
  • Neuroendocrine cancers

In addition to his clinical activities, Dr. Kankeu Fonkoua has a special interest in the development of novel combinatorial immunotherapeutic strategies for hepatobiliary cancers.

  • Gastrointestinal Oncology
  • Hepatobiliary cancers
  • Upper GI Cancers
  • Translational Immuno-Oncology
  • Cellular Immunotherapy
  • Developmental Therapeutics
  1. 2021
    FellowHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 2018
    Residency - Internal MedicinePenn State University-Hershey Medical Center
  3. 2015
    MD - MedicinePenn State College of Medicine

Certifications

  1. 2019
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2021
    Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (BMSF DCTCDP)Bristol Myers Squibb Foundation
  2. 2021
    Mayo Clinic Hepatobiliary SPORE Career Enhancement Program (CEP) AwardMayo Clinic
  3. 2020
    Outstanding Hematology/Oncology FellowThe Minnesota Society of Clinical Oncology
  4. 2020
    Young Investigator AwardAmerican Society of Clinical Oncology
  5. 2018
    Department of Medicine Housestaff Excellence in Research Award, Penn State Hershey Medical Center
  6. 2017
    Resident Travel Award to attend ASCO Annual MeetingAmerican Society of Clinical Oncology
  7. 2016
    Stanford Clinical Teaching Framework CertificationStanford University
  8. 2016
    Resident Travel Award to attend ASCO Annual MeetingAmerican Society of Clinical Oncology

Professional memberships

  1. 2019 - present
    Active MemberSociety for Immunotherapy of Cancer (SITC)
  2. 2017 - present
    Active MemberAmerican Association for Cancer Research
  3. 2015 - present
    Active MemberAmerican Society of Clinical Oncology

Publications